Test ID CHFXH Chromosome Analysis, Hematologic Disorders, Fixed Cells
Necessary Information
A pathology and/or flow cytometry report may be requested by the Genomics Laboratory to optimize testing and aid in interpretation of results.
Specimen Required
Provide a reason for referral and specimen type with each specimen. The laboratory will not reject testing if this information is not provided, but appropriate testing and interpretation may be compromised or delayed.
Specimen Volume: 2 mL
Additional Information: Advise Express Mail or equivalent if not on courier service.
Forms
New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available in Special Instructions:
Useful For
Assisting in the diagnosis and classification of certain malignant hematological disorders
Evaluating the prognosis of patients with certain malignant hematologic disorders
Monitoring effects of treatment
Monitoring patients in remission
Reflex Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
_ML20 | Metaphases, 1-19 | No, (Bill Only) | No |
_M25 | Metaphases, 20-25 | No, (Bill Only) | No |
_MG25 | Metaphases, >25 | No, (Bill Only) | No |
_STAC | Ag-Nor/CBL Stain | No, (Bill Only) | No |
Testing Algorithm
This test only includes a charge for professional interpretation of results and does not include charges for analysis.
Analysis charges will be incurred for total work performed, and generally include 2 banded karyograms and the analysis of 20 or more metaphase cells for this test. If no metaphase cells are available for analysis, no analysis charges will be incurred. If additional analysis work is required, additional charges may be incurred. See the Method Description for specific details.
The following algorithms are available:
-Acute Promyelocytic Leukemia: Guideline to Diagnosis and Follow-up
-Bone Marrow Staging for Known or Suspected Malignant Lymphoma Algorithm
-Multiple Myeloma: Laboratory Screening
-Myeloproliferative Neoplasm: A Diagnostic Approach to Bone Marrow Evaluation
Special Instructions
- Multiple Myeloma: Laboratory Screening
- Myeloproliferative Neoplasm: A Diagnostic Approach to Bone Marrow Evaluation
- Bone Marrow Staging for Known or Suspected Malignant Lymphoma Algorithm
- Acute Promyelocytic Leukemia: Guideline to Diagnosis and Follow-up
- Informed Consent for Genetic Testing (Spanish)
Method Name
Chromosome Analysis on Fixed Cells
Reporting Name
Chromosomes, Hematol Fixed CellsSpecimen Type
VariesSpecimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Varies | Ambient (preferred) | |
Refrigerated |
Reference Values
An interpretative report will be provided.
Day(s) Performed
Monday through Friday
Report Available
10 to 11 daysPerforming Laboratory

Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
88291
88264 w/modifier 52 (if appropriate)
88264 (if appropriate)
88264, 88285 (if appropriate)
88283 (if appropriate)
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CHFXH | Chromosomes, Hematol Fixed Cells | In Process |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
38487 | Result Summary | 50397-9 |
38488 | Interpretation | 69965-2 |
38489 | Result | 62356-1 |
38490 | Reason for Referral | 42349-1 |
38491 | Specimen | 31208-2 |
38492 | Source | 31208-2 |
38493 | Method | 85069-3 |
38494 | Banding Method | 62359-5 |
38495 | Additional Information | 48767-8 |
38496 | Released By | 18771-6 |